Spago Nanomedical is a company that develops nanomedical products for cancer diagnostics and treatment. It focuses on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor-selective radionuclide treatment. The company utilizes a patented platform of polymeric materials that can enable accurate diagnosis and treatment of solid tumors.